Login / Signup

Nemolizumab Improves Patient-Reported Symptoms of Atopic Dermatitis with Pruritus: Post Hoc Analysis of a Japanese Phase III Randomized Controlled Trial.

Kenji KabashimaTakayo MatsumuraHiroshi KomazakiMakoto Kawashimanull null
Published in: Dermatology and therapy (2023)
JapicCTI-173740 (registered 20 October 2017).
Keyphrases
  • phase iii
  • atopic dermatitis
  • patient reported
  • randomized controlled trial
  • open label
  • study protocol
  • clinical trial
  • double blind
  • placebo controlled
  • phase ii
  • sleep quality
  • physical activity
  • depressive symptoms